|
Physician attempted to use a pacific xtreme pta balloon with a 6french 45cm non-medtronic sheath and 6mm spider fx embolic protection device during treatment of a 20mm calcified lesion in the patient's proximal right popliteal artery.Severe vessel calcification is reported.Artery diameter reported as 6mm.Lesion exhibited 80% stenosis.A non-medtronic inflation device was used with 50/50 saline contrast mix for balloon inflation.There was no damage noted to packaging, i.E.Shelf carton, hoop/tray.There were no issues noted when removing the device from the hoop/tray.The device was prepped per ifu without issue.The device was passed through a previously deployed stent.No resistance was noted during advancement. a balloon burst is reported ay 8atm on first inflation.No fragments were left in the patient.No vessel damage.A second pacific xtreme pta balloon was opened and prepped without issue.The second pacific xtreme balloon burst at 8atm on first inflation.No balloon fragmentation.No fragments were left in the patient. no vessel damage.An additional balloon of the identical size was taken from the customers consignment to complete the angioplasty.No patient injury reported.
|
|
Product analysis: the pacific xtreme pta device was returned to medtronic investigation lab for evaluation.The device was received coiled in a biohazard bag.A 20ml water filled syringe was used to flush the device and a steady stream of water was observed exiting the tip.A 0.018¿ guidewire from the lab was loaded through the tip and exited the inflation port of the hub without any difficulty.The balloon was pressurized, but no pressure could be maintained, and the balloon exhibited a pinhole leak beside the proximal marker band leak.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|